VCA Inc agreed to be sold to Mars, announced on Jan 9, 2017.
8-KBarclays Capitalfirm advised the seller.
8-KBDT & MSD Partnersfirm and Morgan Stanley & Co.firm advised the buyer.
8-KThe filing puts the value at $9.1B.
8-KBarclays Capitalfirm also worked on Surgery Partners, Incdeal, on Oct 26, 2026.
8-K
At a glance
Who was on each side
Seller's adviserBarclays Capital
The companyVCA Inc$9.1Btransaction valueJan 9, 2017
Also on the deal: J.P. Morgan (lender), J.P. Morgan & Co (lender)
Parties
first 2 of 6
| Party | Role | Source |
|---|---|---|
| Mars | Buyer | 8-K |
| Barclays Capital | Seller's adviser | 8-K |
4 more parties
Sign up free to see the first 5, or become a member to see all 6.
Value
| Kind | Amount | Basis | Source |
|---|---|---|---|
| Price | $9.1B | transaction value | 8-K |
More deals
first 2 of 11
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 26, 2026 | Surgery Partners, Inc · Sale | Barclays Capital, Centerview Partners | 8-K |
| Oct 20, 2026 | Prudential of Brazil and Prudential of Mexico · Sale | Morgan Stanley & Co., Goldman Sachs & Co. | 8-K |
9 more deals
Deals with Barclays Capital, BDT & MSD Partners and Morgan Stanley & Co..
Sign up free to see the first 5, or become a member to see all 11.